133 related articles for article (PubMed ID: 36356494)
21. Cytological-negative pleural effusion can be an alternative liquid biopsy media for detection of EGFR mutation in NSCLC patients.
Song Z; Wang W; Li M; Liu J; Zhang Y
Lung Cancer; 2019 Oct; 136():23-29. PubMed ID: 31421258
[TBL] [Abstract][Full Text] [Related]
22. A novel, rapid point-of-care test for lung cancer patients to detect epidermal growth factor receptor gene mutations by using real-time droplet-PCR and fresh liquid cytology specimens.
Asaka S; Yoshizawa A; Matsuda K; Yamaguchi A; Yamamoto H; Shiina T; Nakata R; Ogawa K; Zhang M; Honda T
Oncol Rep; 2017 Feb; 37(2):1020-1026. PubMed ID: 27922678
[TBL] [Abstract][Full Text] [Related]
23. EGFR mutational genotyping of liquid based cytology samples obtained via fine needle aspiration (FNA) at endobronchial ultrasound of non-small cell lung cancer (NSCLC).
Reynolds JP; Tubbs RR; Minca EC; MacNamara S; Almeida FA; Ma PC; Pennell NA; Cicenia JC
Lung Cancer; 2014 Nov; 86(2):158-63. PubMed ID: 25263855
[TBL] [Abstract][Full Text] [Related]
24. Concordance of Cytological Specimens with Histological Tissue for Detection of Epidermal Growth Factor Receptor Mutation in Non-Small Cell Lung Cancer: A Systematic Review.
Chua TH; Chuah KL
Acta Cytol; 2022; 66(1):61-71. PubMed ID: 34706365
[TBL] [Abstract][Full Text] [Related]
25. EGFR mutation testing using archival-stained smears in non-small cell lung carcinoma.
Ozluk Y; Firat P; Yegen G; Hocaoglu J; Tas S; Yilmazbayhan D
Cytopathology; 2017 Feb; 28(1):35-45. PubMed ID: 27389045
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of EGFR mutation status in cytology specimens: an institutional experience.
Aisner DL; Deshpande C; Baloch Z; Watt CD; Litzky LA; Malhotra B; Sepulveda AR; Langer C; Evans T; Van Deerlin VM
Diagn Cytopathol; 2013 Apr; 41(4):316-23. PubMed ID: 22102479
[TBL] [Abstract][Full Text] [Related]
27. EGFR mutation testing in pulmonary adenocarcinoma: evaluation of tumor cell number and tumor percent in paraffin sections of 120 small biopsies.
Scarpino S; Pulcini F; Di Napoli A; Giubettini M; Ruco L
Lung Cancer; 2015 Jan; 87(1):8-13. PubMed ID: 25468201
[TBL] [Abstract][Full Text] [Related]
28. Detection of EGFR and KRAS Mutation by Pyrosequencing Analysis in Cytologic Samples of Non-Small Cell Lung Cancer.
Lee SE; Lee SY; Park HK; Oh SY; Kim HJ; Lee KY; Kim WS
J Korean Med Sci; 2016 Aug; 31(8):1224-30. PubMed ID: 27478332
[TBL] [Abstract][Full Text] [Related]
29. Adequacy of small biopsy and cytology specimens for comprehensive genomic profiling of patients with non-small-cell lung cancer to determine eligibility for immune checkpoint inhibitor and targeted therapy.
Faber E; Grosu H; Sabir S; San Lucas FA; Barkoh BA; Bassett RL; Luthra R; Stewart J; Roy-Chowdhuri S
J Clin Pathol; 2022 Sep; 75(9):612-619. PubMed ID: 33952592
[TBL] [Abstract][Full Text] [Related]
30. Sample features associated with success rates in population-based EGFR mutation testing.
Shiau CJ; Babwah JP; da Cunha Santos G; Sykes JR; Boerner SL; Geddie WR; Leighl NB; Wei C; Kamel-Reid S; Hwang DM; Tsao MS
J Thorac Oncol; 2014 Jul; 9(7):947-956. PubMed ID: 24922009
[TBL] [Abstract][Full Text] [Related]
31. Real-world data of EGFR mutation testing in Chinese non-small cell carcinoma: Low tumor cell number and tumor cellularity can be accepted.
Gu Y; Li Y; Zhao S; Jin M; Lu J; Jiang X
Pathol Res Pract; 2022 Aug; 236():153965. PubMed ID: 35700580
[TBL] [Abstract][Full Text] [Related]
32. Next-generation sequencing of lung cancer EGFR exons 18-21 allows effective molecular diagnosis of small routine samples (cytology and biopsy).
de Biase D; Visani M; Malapelle U; Simonato F; Cesari V; Bellevicine C; Pession A; Troncone G; Fassina A; Tallini G
PLoS One; 2013; 8(12):e83607. PubMed ID: 24376723
[TBL] [Abstract][Full Text] [Related]
33. Poor cell block adequacy rate for molecular testing improved with the addition of Diff-Quik-stained smears: Need for better cell block processing.
Harada S; Agosto-Arroyo E; Levesque JA; Alston E; Janowski KM; Coshatt GM; Eltoum IA
Cancer Cytopathol; 2015 Aug; 123(8):480-7. PubMed ID: 25955105
[TBL] [Abstract][Full Text] [Related]
34. Cryobiopsy increases the EGFR detection rate in non-small cell lung cancer.
Haentschel M; Boeckeler M; Ehab A; Wagner R; Spengler W; Steger V; Boesmueller H; Horger M; Lewis RA; Fend F; Kanz L; Bonzheim I; Hetzel J
Lung Cancer; 2020 Mar; 141():56-63. PubMed ID: 31955001
[TBL] [Abstract][Full Text] [Related]
35. A comparison of ARMS and mutation specific IHC for common activating EGFR mutations analysis in small biopsy and cytology specimens of advanced non small cell lung cancer.
Wang X; Wang G; Hao Y; Xu Y; Zhang L
Int J Clin Exp Pathol; 2014; 7(7):4310-6. PubMed ID: 25120814
[TBL] [Abstract][Full Text] [Related]
36. Cytology smears as diagnostic material for EGFR gene testing in non-small cell lung cancer.
Powrózek T; Krawczyk P; Pankowski J; Reszka K; Jakubiak M; Obrochta A; Wojas-Krawczyk K; Buczkowski J; Milanowski J
Tumori; 2015 Nov; 101(6):e151-3. PubMed ID: 26108238
[TBL] [Abstract][Full Text] [Related]
37. Programmed death-ligand 1 testing of lung cancer cytology specimens obtained with bronchoscopy.
Stoy SP; Rosen L; Mueller J; Murgu S
Cancer Cytopathol; 2018 Feb; 126(2):122-128. PubMed ID: 29053224
[TBL] [Abstract][Full Text] [Related]
38. Sequential small cell transformation and T790M mutation in an epidermal growth factor-mutant lung adenocarcinoma: A rare occurrence with significant management implications.
Shastri M; Gupta P; Gupta N; Singh N; Bal A; Srinivasan R; Khosla D
Cytopathology; 2022 Nov; 33(6):732-737. PubMed ID: 35867808
[TBL] [Abstract][Full Text] [Related]
39. [Correlation between the Expression of PD-L1 in Pleural Effusion of Lung Adenocarcinoma and the Clinicopathological Features and Molecular Changes].
Ma H; Jia J; Guo H; Zhao H; Wang C; Zhao L; Sun Y; Li W; Zhang Z
Zhongguo Fei Ai Za Zhi; 2020 Mar; 23(3):150-155. PubMed ID: 32209183
[TBL] [Abstract][Full Text] [Related]
40. Comparative study of epidermal growth factor receptor mutation analysis on cytology smears and surgical pathology specimens from primary and metastatic lung carcinomas.
Khode R; Larsen DA; Culbreath BC; Parrish S; Walker KL; Sayage-Rabie L; Beissner RS; Rao A
Cancer Cytopathol; 2013 Jul; 121(7):361-9. PubMed ID: 23364874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]